Results 161 to 170 of about 25,691 (210)

Topotecan-induced Bronchiolitis

Southern Medical Journal, 2004
Topotecan HCl is an antitumor drug exhibiting topoisomerase 1-inhibitory activity. Topotecan is used in the treatment of metastatic carcinoma of the ovary and as second-line treatment of small-cell lung cancer. Reported dose-limiting adverse reactions to topotecan are primarily hematologic in nature.
Colin C, Edgerton, Matthew, Gilman, Bernard J, Roth   +2 more
openaire   +2 more sources

Topotecan

Reactions Weekly, 2002
Ines Mader, Patrizia E. Fürst-Weger, Robert M. Mader, Elisabeth I. Semenitz, Robert Terkola, Sabine M. Wassertheurer   +5 more
  +5 more sources

Topotecan

Journal of Pediatric Oncology Nursing, 1992
D L, Betcher, N, Burnham
openaire   +2 more sources

Topotecan

Reactions Weekly, 2008
openaire   +2 more sources

Topotecan

Der Onkologe, 1998
R. Kath, H. D. Peters, C.-P. Schneider, K. Höffken   +3 more
openaire   +1 more source

Topotecan

Reactions Weekly, 2004
openaire   +2 more sources

Topotecan

Reactions Weekly, 2017
openaire   +2 more sources

Topotecan

Reactions Weekly, 2015
  +4 more sources

TOPOTECAN

2010
Ines Mader, Patrizia Fürst-Weger, Robert Mader, Elisabeth Nogler-Semenitz, Sabine Wassertheurer   +4 more
openaire   +2 more sources

Oral delivery of topotecan in polymeric nanoparticles: Lymphatic distribution and pharmacokinetics

Journal of Controlled Release, 2021
Yong-Bok Lee
exaly